14 unchanged sentences
October 3 through October 30, 2022 19,483 $ 43.68 — $ 3,292,882,444
−Removed: November 1 through November 30, 2021 4,687 $ 44.71 — $ 5,292,881,709
+Added: October 31 through November 30, 2022 39,821 $ 47.85 — $ 3,292,882,444
December 1 through December 31, 2022 415,886 $ 51.29 — $ 3,292,882,444
1 unchanged sentence
(a) See Note 12 .
−Removed: (b) Represents (i) 44,604 shares of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of awards under our long-term incentive programs and (ii) the open market purchase by the trustee of 2,086 shares of common stock in connection with the reinvestment of dividends paid on common stock held in trust for employees who deferred receipt of performance share awards.
2022 Form 10-K 24
+Added: (b) Represents (i) 473,126 shares of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of awards under our long-term incentive programs and (ii) the open market purchase by the trustee of 2,064 shares of common stock in connection with the reinvestment of dividends paid on common stock held in trust for employees who deferred receipt of performance share awards.
PEER GROUP PERFORMANCE GRAPH
−Removed: The following graph assumes a $100 investment on December 31, 2016, and reinvestment of all dividends, in each of the Company’s Common Stock, the S&P 500 Index, and a composite peer group of the major U.S.
+Added: The following graph assumes a $100 investment on December 31, 2017, and reinvestment of all dividends, in each of the Company’s Common Stock, a composite peer group of the major U.S.
and European-based pharmaceutical companies, which are:
−Removed: AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Roche Holding AG and Sanofi SA.
+Added: AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Roche Holding AG and Sanofi SA, the S&P 500 Index and the NYSE Arca Pharmaceutical Index (DRG index).
Five Year Performance
3 unchanged sentences
S&P 500 $100.0 $95.6 $125.7 $148.8 $191.5 $156.8
−Removed: 2021 Form 10-K 25
+Added: DRG Index $100.0 $107.5 $127.3 $138.4 $170.7 $183.9
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.